Registration is officially open for the 2026 Komen Houston Race for the Cure, set for October 3 at Sam Houston Park, where organizers are aiming to raise $1,006,600 to fund breast cancer research, care, and awareness efforts. The event will bring together survivors, people living with metastatic breast cancer, and families from across the region for a morning of competitive racing, a one-mile walk or run, and a Hope Village celebration.
According to CW39 Houston, check-in and on-site registration open at 6:15 a.m. on October 3, followed by an opening ceremony at 7:30 a.m. and the start of the roughly three-mile 5K at 8 a.m. Survivors and those living with metastatic breast cancer are invited to meet at Hope Village at 7 a.m., ahead of a Pathway of Hope and survivor parade held at the start line. The full event is located at Sam Houston Park, 1000 Bagby St., and Hope Village's own celebration kicks off at 10 a.m.
Adult registration costs $45, with a $55 fee for those registering virtually, while youth registration is $35. Every registered participant receives an event t-shirt, and those who sign up by September 6 can pay extra to have their shirts mailed ahead of race day; anyone registering after that date can pick up their shirt during packet pickup or on race morning. Packet pickup details have not yet been announced and are expected to be updated as the event approaches, per the same report. Only service animals are permitted at the race.
How Houstonians Can Get Involved
Organizers say Houstonians can take part by registering individually, forming or joining a team, fundraising, or simply donating, and participants can begin building teams and fundraising campaigns now ahead of the October event. Susan G. Komen organizes the Houston race, which has become one of the city's largest annual gatherings for breast cancer awareness. The October 2024 edition of the race drew more than 7,000 registered participants to the same Sam Houston Park grounds and also targeted more than $1 million in fundraising, according to Click2Houston.
Why the Houston Fundraising Matters
Susan G. Komen was founded in Dallas in 1982 by Nancy G. Brinker, who launched the organization to honor a promise made to her dying sister, Susan Goodman Komen, and the group's presence in the region deepened with the creation of the Komen Houston Affiliate in 1990, according to the National Women's History Museum. Since its founding, Komen has invested nearly $1.1 billion in breast cancer research across more than 2,800 grants and 500 clinical trials worldwide, making it the largest non-governmental funder of breast cancer research globally. Komen-funded research has played a role in all 19 breast cancer drugs approved by the FDA since 2012.
The stakes are especially high in Harris County, which experiences the highest total annual volume of new female breast cancer diagnoses in Texas, averaging roughly 2,300 new cases per year, according to National Cancer Institute and CDC data cited by the Houston Medical Times. Roughly 650 Black women are diagnosed with breast cancer in Harris County each year, and MD Anderson Cancer Center data reported in 2023 found they face a 30% higher mortality rate from the disease than white women in the same county. In response, MD Anderson launched the Texas Health Equity Alliance for Breast Cancer in October 2023, bringing together more than 20 local organizations with a goal of cutting that mortality gap in half within five years.
National Trends Behind the Local Push
Susan G. Komen projects that roughly 321,910 U.S. women will be diagnosed with invasive breast cancer in 2026, along with 60,730 cases of non-invasive ductal carcinoma in situ, and that 42,140 women will die from the disease this year. The organization's 2026 Progress Outlook, reported by PharmExec, found that U.S. breast cancer mortality rates dropped 44% between 1989 and 2023, averting an estimated 546,000 deaths, even as invasive breast cancer incidence has grown 1% annually from 2013 to 2022 and 1.4% annually among women under 50.
Screening access has also become a bigger part of the national conversation. A federal Food and Drug Administration mandate under the Mammography Quality Standards Act took effect in September 2024, requiring mammography facilities nationwide to tell patients whether their breast tissue is dense and to explain that dense tissue can obscure tumors and raise cancer risk. In Texas, state lawmakers introduced legislation in early 2025, backed by Komen, aimed at eliminating patients' out-of-pocket costs for supplemental imaging like MRIs and ultrasounds as well as genetic testing, since standard mammograms are often fully covered while follow-up diagnostic imaging can carry steep costs.
Fundraising from events like the Houston Race for the Cure feeds directly into that research and advocacy infrastructure, organizers say, supporting both global grant-making and local coalitions such as MD Anderson's THEAL initiative. With registration now open, Houstonians looking to take part have just over a month to build teams, secure early t-shirt shipping, and start fundraising before the race steps off on October 3.
-4.webp?w=160&h=400&fit=crop&crop=edges)